Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 99

1.

Pituitary volume in schizophrenia spectrum disorders.

Romo-Nava F, Hoogenboom WS, Pelavin PE, Alvarado JL, Bobrow LH, Macmaster FP, Keshavan M, McCarley RW, Shenton ME.

Schizophr Res. 2013 May;146(1-3):301-7. doi: 10.1016/j.schres.2013.02.024. Epub 2013 Mar 19.

2.

Corticolimbic functional connectivity in adolescents with bipolar disorder.

Wang F, Bobrow L, Liu J, Spencer L, Blumberg HP.

PLoS One. 2012;7(11):e50177. doi: 10.1371/journal.pone.0050177. Epub 2012 Nov 21.

3.

Fiber geometry in the corpus callosum in schizophrenia: evidence for transcallosal misconnection.

Whitford TJ, Savadjiev P, Kubicki M, O'Donnell LJ, Terry DP, Bouix S, Westin CF, Schneiderman JS, Bobrow L, Rausch AC, Niznikiewicz M, Nestor PG, Pantelis C, Wood SJ, McCarley RW, Shenton ME.

Schizophr Res. 2011 Oct;132(1):69-74. doi: 10.1016/j.schres.2011.07.010. Epub 2011 Aug 9.

4.

Pathological and mammographic prognostic factors for screen detected cancers in a multi-centre randomised, controlled trial of mammographic screening in women from age 40 to 48 years.

Bennett RL, Evans AJ, Kutt E, Record C, Bobrow LG, Ellis IO, Hanby A, Moss SM.

Breast. 2011 Dec;20(6):525-8. doi: 10.1016/j.breast.2011.05.008. Epub 2011 Jun 21.

5.

A selective review of volumetric and morphometric imaging in schizophrenia.

Levitt JJ, Bobrow L, Lucia D, Srinivasan P.

Curr Top Behav Neurosci. 2010;4:243-81. Review.

PMID:
21312403
6.

Gray matter volume reduction in rostral middle frontal gyrus in patients with chronic schizophrenia.

Kikinis Z, Fallon JH, Niznikiewicz M, Nestor P, Davidson C, Bobrow L, Pelavin PE, Fischl B, Yendiki A, McCarley RW, Kikinis R, Kubicki M, Shenton ME.

Schizophr Res. 2010 Nov;123(2-3):153-9. doi: 10.1016/j.schres.2010.07.027. Epub 2010 Sep 6.

7.

Axillary lymph node drainage pathways from intradermal and intraparenchymal breast planes.

Fowler JC, Solanki CK, Ballinger JR, Ravichandran D, Douglas-Jones A, Lawrence D, Bobrow L, Purushotham AD, Peters AM.

J Surg Res. 2010 Jun 1;161(1):69-75. doi: 10.1016/j.jss.2009.01.003. Epub 2009 Jan 31.

PMID:
19439325
8.

A pilot study of dual-isotope lymphoscintigraphy for breast sentinel node biopsy comparing intradermal and intraparenchymal injection.

Fowler JC, Solanki CK, Guenther I, Barber R, Miller F, Bobrow L, Ravichandran D, Lawrence D, Ballinger JR, Douglas-Jones A, Purushotham AD, Peters AM.

Eur J Surg Oncol. 2009 Oct;35(10):1041-7. doi: 10.1016/j.ejso.2009.02.018. Epub 2009 Apr 10.

PMID:
19362444
9.

Intracystic papillary carcinoma; solid variant in a male breast - case report and review of the literature.

Poultsidis AA, Kalra S, Bobrow L, Purushotham AD.

J BUON. 2002 Apr-Jun;7(2):157-9.

PMID:
17577282
10.

The management of radial scars of the breast - does core biopsy help?

Britton PD, Wishart GC, Ravichandran D, McIntosh S, Bobrow L, Purushotham AD.

J BUON. 2002 Apr-Jun;7(2):137-40.

PMID:
17577277
11.

Radiological and pathological findings of interval cancers in a multi-centre, randomized, controlled trial of mammographic screening in women from age 40-41 years.

Evans AJ, Kutt E, Record C, Waller M, Bobrow L, Moss S.

Clin Radiol. 2007 Apr;62(4):348-52. Epub 2007 Jan 26.

PMID:
17331828
12.

Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial.

Moss SM, Cuckle H, Evans A, Johns L, Waller M, Bobrow L; Trial Management Group.

Lancet. 2006 Dec 9;368(9552):2053-60.

PMID:
17161727
13.

Differential expression of selected histone modifier genes in human solid cancers.

Ozda─č H, Teschendorff AE, Ahmed AA, Hyland SJ, Blenkiron C, Bobrow L, Veerakumarasivam A, Burtt G, Subkhankulova T, Arends MJ, Collins VP, Bowtell D, Kouzarides T, Brenton JD, Caldas C.

BMC Genomics. 2006 Apr 25;7:90.

14.

Terahertz pulsed imaging of human breast tumors.

Fitzgerald AJ, Wallace VP, Jimenez-Linan M, Bobrow L, Pye RJ, Purushotham AD, Arnone DD.

Radiology. 2006 May;239(2):533-40. Epub 2006 Mar 16.

PMID:
16543586
15.

Impact of a national external quality assessment scheme for breast pathology in the UK.

Ellis IO, Coleman D, Wells C, Kodikara S, Paish EM, Moss S, Al-Sam S, Anderson N, Bobrow L, Buley I, Connolly CE, Dallimore NS, Hales S, Hanby A, Humphreys S, Knox F, Lowe J, Macartney J, Nash R, Parham D, Patnick J, Pinder SE, Quinn CM, Robertson AJ, Shrimankar J, Walker RA, Winder R.

J Clin Pathol. 2006 Feb;59(2):138-45.

16.

The NHS breast screening programme (pathology) EQA: experience in recent years relating to issues involved in individual performance appraisal.

Parham DM, Coleman D, Kodikara S, Moss S, Ellis IO, Al-Sam S, Anderson N, Bobrow L, Buley I, Connolly CE, Dallimore NS, Hales S, Hanby A, Humphreys S, Knox F, Lowe J, Macartney J, Nash R, Patnick J, Pinder SE, Quinn CM, Robertson AJ, Shrimankar J, Walker RA, Wells C, Winder R, Patel N.

J Clin Pathol. 2006 Feb;59(2):130-7.

17.

Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial.

Purushotham AD, Upponi S, Klevesath MB, Bobrow L, Millar K, Myles JP, Duffy SW.

J Clin Oncol. 2005 Jul 1;23(19):4312-21.

PMID:
15994144
18.

The value of immunohistochemistry in sentinel lymph node histopathology in breast cancer.

Klevesath MB, Bobrow LG, Pinder SE, Purushotham AD.

Br J Cancer. 2005 Jun 20;92(12):2201-5.

19.

Radioguided occult lesion localisation (ROLL) and sentinel node biopsy for impalpable invasive breast cancer.

Patel A, Pain SJ, Britton P, Sinnatamby R, Warren R, Bobrow L, Barber RW, Peters AM, Purushotham AD.

Eur J Surg Oncol. 2004 Nov;30(9):918-23.

PMID:
15498634
20.

Influence of annual mammography from age 40 on breast cancer pathology.

Anderson TJ, Waller M, Ellis IO, Bobrow L, Moss S.

Hum Pathol. 2004 Oct;35(10):1252-9.

PMID:
15492993
21.

Reducing the workload of a histopathology department.

Love K, Bobrow L.

Histopathology. 2004 Oct;45(4):415-6. No abstract available.

PMID:
15469483
22.

Targeted disruption of the 3p12 gene, Dutt1/Robo1, predisposes mice to lung adenocarcinomas and lymphomas with methylation of the gene promoter.

Xian J, Aitchison A, Bobrow L, Corbett G, Pannell R, Rabbitts T, Rabbitts P.

Cancer Res. 2004 Sep 15;64(18):6432-7.

23.

Can breast MRI help in the management of women with breast cancer treated by neoadjuvant chemotherapy?

Warren RM, Bobrow LG, Earl HM, Britton PD, Gopalan D, Purushotham AD, Wishart GC, Benson JR, Hollingworth W.

Br J Cancer. 2004 Apr 5;90(7):1349-60.

24.

Mammographic axillary node calcification caused by metastatic breast carcinoma.

Groves AM, Warren R, Bobrow LG.

Breast. 2002 Jun;11(3):267-9. No abstract available.

PMID:
14965680
25.

Sentinel lymph node biopsy in impalpable breast cancer.

McIntosh SA, Ravichandran D, Balan KK, Bobrow L, Wishart GC, Purushotham AD.

Breast. 2001 Feb;10(1):82-3.

PMID:
14965566
26.

BCL-6 is expressed in breast cancer and prevents mammary epithelial differentiation.

Logarajah S, Hunter P, Kraman M, Steele D, Lakhani S, Bobrow L, Venkitaraman A, Wagner S.

Oncogene. 2003 Aug 28;22(36):5572-8.

PMID:
12944904
27.

Molecular classification of breast carcinomas using tissue microarrays.

Callagy G, Cattaneo E, Daigo Y, Happerfield L, Bobrow LG, Pharoah PD, Caldas C.

Diagn Mol Pathol. 2003 Mar;12(1):27-34.

PMID:
12605033
28.

BRCA1/2 mutation status influences somatic genetic progression in inherited and sporadic epithelial ovarian cancer cases.

Ramus SJ, Pharoah PD, Harrington P, Pye C, Werness B, Bobrow L, Ayhan A, Wells D, Fishman A, Gore M, DiCioccio RA, Piver MS, Whittemore AS, Ponder BA, Gayther SA.

Cancer Res. 2003 Jan 15;63(2):417-23.

29.

The significance of intramammary nodes in primary breast cancer.

Upponi S, Kalra S, Poultsidis A, Bobrow L, Purushotham AD.

Eur J Surg Oncol. 2001 Dec;27(8):707-8.

PMID:
11735164
30.

Paraneoplastic cerebellar degeneration: an unusual presentation of breast carcinoma.

Gaston M, Jadav A, Bobrow L, Purushotham AD.

Eur J Surg Oncol. 2001 Sep;27(6):606-7. No abstract available.

PMID:
11520098
31.

DNA replication licensing and human cell proliferation.

Stoeber K, Tlsty TD, Happerfield L, Thomas GA, Romanov S, Bobrow L, Williams ED, Williams GH.

J Cell Sci. 2001 Jun;114(Pt 11):2027-41.

33.

Lobular carcinoma in situ on core biopsy-what is the clinical significance?

O'Driscoll D, Britton P, Bobrow L, Wishart GC, Sinnatamby R, Warren R.

Clin Radiol. 2001 Mar;56(3):216-20.

PMID:
11247699
36.

Can we be sure about a radiological diagnosis of fat necrosis of the breast?

Harrison RL, Britton P, Warren R, Bobrow L.

Clin Radiol. 2000 Feb;55(2):119-23.

PMID:
10657157
37.

The genetic epidemiology of early-onset epithelial ovarian cancer: a population-based study.

Stratton JF, Thompson D, Bobrow L, Dalal N, Gore M, Bishop DT, Scott I, Evans G, Daly P, Easton DF, Ponder BA.

Am J Hum Genet. 1999 Dec;65(6):1725-32.

38.

Minimal breast cancer: evaluation of histology and biological marker expression.

Dublin EA, Millis RR, Smith P, Bobrow LG.

Br J Cancer. 1999 Jul;80(10):1608-16.

39.
40.

Increased frequency of TP53 mutations in BRCA1 and BRCA2 ovarian tumours.

Ramus SJ, Bobrow LG, Pharoah PD, Finnigan DS, Fishman A, Altaras M, Harrington PA, Gayther SA, Ponder BA, Friedman LS.

Genes Chromosomes Cancer. 1999 Jun;25(2):91-6.

PMID:
10337991
41.
42.

c-erbB-3 protein expression in ductal carcinoma in situ of the breast.

Bobrow LG, Millis RR, Happerfield LC, Gullick WJ.

Eur J Cancer. 1997 Oct;33(11):1846-50.

PMID:
9470844
43.

Changing to core biopsy in an NHS breast screening unit.

Britton PD, Flower CD, Freeman AH, Sinnatamby R, Warren R, Goddard MJ, Wight DG, Bobrow L.

Clin Radiol. 1997 Oct;52(10):764-7.

PMID:
9366536
44.

Angiogenesis and inflammation in invasive carcinoma of the breast.

Lee AH, Happerfield LC, Bobrow LG, Millis RR.

J Clin Pathol. 1997 Aug;50(8):669-73.

45.

Angiogenesis and inflammation in ductal carcinoma in situ of the breast.

Lee AH, Happerfield LC, Bobrow LG, Millis RR.

J Pathol. 1997 Feb;181(2):200-6.

PMID:
9120726
46.

A breast/ovarian cancer patient with germline mutations in both BRCA1 and BRCA2.

Ramus SJ, Friedman LS, Gayther SA, Ponder BA, Bobrow L, van der Looji M, Papp J, Olah E.

Nat Genet. 1997 Jan;15(1):14-5. No abstract available.

PMID:
8988162
47.

Sequence variants of the estrogen receptor (ER) gene found in breast cancer patients with ER negative and progesterone receptor positive tumors.

Iwase H, Greenman JM, Barnes DM, Hodgson S, Bobrow L, Mathew CG.

Cancer Lett. 1996 Nov 29;108(2):179-84.

PMID:
8973592
48.

Inflammatory infiltrate in invasive lobular and ductal carcinoma of the breast.

Lee AH, Happerfield LC, Millis RR, Bobrow LG.

Br J Cancer. 1996 Sep;74(5):796-801.

49.

Relationship of histologic grade, c-erbB-2 expression, and inflammatory infiltrate to prognosis in carcinoma of the breast.

Lee AH, Bobrow LG.

J Clin Oncol. 1996 Aug;14(8):2406-7. No abstract available.

PMID:
8708736
50.

Adhesion molecule expression and leucocyte trafficking following immunotherapy with recombinant interleukin-2.

Miles DW, Happerfield LC, Bobrow LG, Rubens RD.

Histopathology. 1996 Apr;28(4):301-8.

PMID:
8732338

Supplemental Content

Loading ...
Support Center